chitosan has been researched along with Colonic Neoplasms in 87 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.15) | 18.2507 |
2000's | 8 (9.20) | 29.6817 |
2010's | 43 (49.43) | 24.3611 |
2020's | 35 (40.23) | 2.80 |
Authors | Studies |
---|---|
Bae, CH; Choi, GE; Jeong, YI; Kang, MS; Kim, YJ; Yoon, HM; Yu, YB | 1 |
Chen, J; Hao, R; Ji, X; Li, Z; Liu, Y; Shen, J; Xi, Q; Zheng, C; Zhou, Z | 1 |
Dinesh Kumar, L; Gundloori Vn, R; Jose, J; Killi, N; Kumar, A; Singam, A; Swaminathan, G; Tangudu, NK | 1 |
Chamsai, B; Opanasopit, P; Samprasit, W | 2 |
Cha, BS; Chowdhury, P; Kim, S; Lee, ES; Park, KS; Woo, J; Yoon, T | 1 |
Homayouni Tabrizi, M; Karimi, E; Rahmati, A; Zarei, B | 1 |
Bhaskaran, NA; Cheruku, S; Jitta, SR; Kumar, L; Kumar, N | 1 |
Anbalagan, M; Gor, R; Kesavan, Y; Lazer, LM; Narayan, S; Pathak, S; Ramachandran, I; Ramalingam, S | 1 |
Chen, J; Chen, X; Chen, Z; Lin, D; Liu, D; Liu, Y; Luo, Y; Zhang, J | 1 |
Ali, A; Basit, A; Jan, N; Khan, MM; Khan, S; Madni, A; Rai, N; Shafiq, A; Shah, H | 1 |
Bae, I; Jeong, YI; Jo, J; Kim, D; Kim, DH; Kim, T; Kim, TG; Lee, YJ | 1 |
Abuelmakarem, HS; Ahmed, WA; El-Azab, J; Hamdy, O; Sliem, MA | 1 |
Bedhiafi, T; Billa, N; Dermime, S; Hijji, Y; Idoudi, S; Merhi, M; Sahir, F; Uddin, S | 1 |
Eze, FN; Ovatlarnporn, C; Sajomsang, W; Sripetthong, S | 1 |
Hamed, AA; Hanna, DH; Saad, GR | 1 |
Gou, G; Peng, L; Tian, Z; Wu, X; Yang, J; Yu, N; Zuo, W | 1 |
Alsadooni, JFK; Barzegar, A; Feizi, MAH; Haghi, M | 1 |
Alanazi, IM; Alzahrani, AR; Arulselvan, P; Azlina, MFN; Falemban, AH; Ibrahim, IAA; Shahid, I; Shahzad, N | 1 |
Bhaskar, KV; Bhaskaran, NA; Birangal, SR; Gourishetti, K; Hari, G; Jitta, SR; Kulkarni, OP; Kumar, L; Sharma, P; Verma, R | 1 |
Jia, J; Niu, X; Song, Q; Sun, L; Wang, L; Zhang, H; Zhang, Y; Zhang, Z; Zhao, H; Zheng, C | 1 |
Billa, N; Roberts, CJ; Sabra, R | 1 |
Arun, G; Kannan, PR; Madhan, B; Mary, SA; Senthil Kumar, C; Thangam, R | 1 |
Abdel-Naim, AB; Abdulaal, WH; Ahmed, OAA; Aldawsari, HM; Alhakamy, NA; Asfour, HZ; Bakhrebah, MA; Caraci, F; Caruso, G; Eid, BG; Fahmy, UA; Kurakula, M; Mohamed, AI; N Alomary, M; Okbazghi, SZ | 1 |
Aghaei Vanda, N; Ahmadi, A; Atyabi, F; Ghaderi Sede, MJ; Ghalamfarsa, G; Ghani, S; Ghasemi-Chaleshtari, M; Hassannia, H; Hojjat-Farsangi, M; Irandoust, M; Jadidi-Niaragh, F; Karami, H; Kiaie, SH; Masjedi, A; Nabi Afjadi, M; Namdar, A | 1 |
Alhajj, MJ; Carabali, GA; Ciro, Y; Di Virgilio, AL; Rojas, J; Salamanca, CH | 1 |
Dusane, AC; Indukuri, VV; Janardhanam, LSL; Venuganti, VVK; Verma, P | 1 |
Deshmukh, R | 1 |
Chen, L; Han, S; Ke, C; Niu, G; Ren, J; Su, X | 1 |
Chen, G; Liu, T; Wang, K; Xu, Y; Zhao, Y; Zhu, C | 1 |
Ahmadi, A; Boroumand-Noughabi, S; Hassannia, H; Heydari, M; Hojjat-Farsangi, M; Izadi, S; Jadidi-Niaragh, F; Karoon Kiani, F; Keramati, MR; Masjedi, A; Mohammadi, H; Sadat Eshaghi, F; Salimifard, S; Shahdadnejad, K | 1 |
Hu, C; Shen, C; Sun, C; Zhang, Y | 1 |
Ahmadi, A; Ahmadi, M; Alian, F; Asl, SH; Beyzai, B; Budi, HS; Eshaghi, FS; Ghaderpour, A; Hassannia, H; Izadi, S; Jadidi-Niaragh, F; Mousavi, SM; Nikkhoo, A; Rafiee, B; Sojoodi, M; Timoshin, A | 1 |
Elbarbary, AM; Ghobashy, MM; Hegazy, DE | 1 |
Dong, W; Ma, J; Qiu, T; Tang, M; Wang, Y; Zhang, X | 1 |
Deng, H; Deng, N; Fan, Z; He, J; Li, T; Liao, R; Lv, X; Pang, C; Xu, R; Zheng, Z | 1 |
Faninam, F; Hashemi, M; Kazemi, NM; Khaleghi, S; Mokri, N; Sepehri, Z | 1 |
Chang, PH; Chao, HM; Chern, E; Hsu, SH; Sekine, K | 1 |
Abnous, K; Alibolandi, M; Ramezani, M; Taghavi, S; Taghdisi, SM | 1 |
Abu-Serie, MM; El-Rashidy, FH | 1 |
Ding, S; Ding, Y; Gong, W; Han, S; Qian, L; Tan, L; Wang, C; Xiao, W | 1 |
Li, M; Pan, J; Qiu, J; Shen, Z; Wang, H; Wu, W; Xu, K; Yang, G; Zhang, X; Zhang, Y | 1 |
Barbosa, MA; Castro, F; Gomez-Lazaro, M; Gonçalves, RM; Oliveira, MJ; Pereira, CL; Pinto, ML; Santos, SG; Silva, AM; Teixeira, GQ | 1 |
Wang, J; Yang, X; Yuan, S; Zhai, X; Zou, P | 1 |
Abdel-Aziz, MM; Abu Elella, MH; Mohamed, RR; Sabaa, MW | 1 |
Arafa, K; El-Gazayerly, ON; El-Sherbiny, IM; Shamma, RN | 1 |
Ganesh, M; Jang, HT; Rathnam, G; Sinha, P; Udhumansha, U | 1 |
Tsai, CW; Wang, JH; Young, TH | 1 |
Alkhader, E; Billa, N; Lee, YZ; Roberts, CJ; Rosli, R; Seow, EK; Yuen, KH | 1 |
Hu, TG; Li, L; Wen, P; Wu, H; Zong, MH | 1 |
Li, X; Liu, W; Liu, X; Pan, W; Pang, J; Wang, F; Zhu, Y | 1 |
Fan, G; Gao, F; Han, L; He, X; Huang, X; Qiu, Y; Tang, X; Xu, K; Yin, P; Yuan, Y; Yuan, Z; Zhang, Y | 1 |
Jain, A; Jain, R; Jain, S; Khatik, R; Veer Kohli, D | 1 |
Jing, P; Liang, T; Zhang, Z | 1 |
Crcarevska, MS; Dimchevska, S; Geskovski, N; Glavas-Dodov, M; Goracinova, K; Kuzmanovska, S; Steffansen, B | 1 |
Chung, CW; Chung, KD; Jeong, YI; Kang, DH | 1 |
Choi, K; Jeong, SY; Jun, E; Kim, BS; Kim, IS; Kim, K; Ko, HK; Kwon, IC; Na, JH; Park, JH; Park, S; Ryu, JH; Seo, DH; Yeom, HJ; You, DG | 1 |
Depani, BP; Naik, AA; Nair, HA | 1 |
Anitha, A; Chennazhi, KP; Jayakumar, R; Lakshmanan, VK; Sreeranganathan, M | 1 |
Du, QG; Guo, XY; Han, S; Hao, ZM; Liu, GS; Lv, YF; Wang, P; Zhu, SM | 1 |
Anitha, A; Chennazhi, KP; Deepa, N; Jayakumar, R; Lakshmanan, VK | 1 |
Kanwar, JR; Kanwar, RK; Krishnakumar, S; Mahidhara, G; Prasad, N; Roy, K; Sasidharan, S; Sehgal, R | 1 |
Kong, L; Li, P; Li, S; Peng, Z; Wang, Q; Wang, Y; Yang, Z | 1 |
Atyabi, F; Dinarvand, M; Dinarvand, R; Esmaeili, A; Kiani, M; Mirzaie, Z; Mirzazadeh, F; Soleimani, M | 1 |
Aoki, I; Bakalova, R; Lazarova, D; Murayama, S; Nikolova, B; Tsoneva, I; Zhelev, Z | 1 |
Jain, A; Jain, SK | 2 |
Gou, M; Li, X; Li, Z; Peng, F; Qian, Z; Sun, L | 1 |
Ahmed, A; Aminabhavi, TM; Lane, MA; Palacios, A; Rudzinski, WE | 1 |
Chen, YQ; Han, FS; Lin, MB; Xu, JM; Yang, P; Yang, SJ | 1 |
Chirachanchai, S; Fangkangwanwong, J; Sae-Liang, N; Sereemaspun, A; Sriworarat, C | 1 |
Bhatia, RK; Chandra, R; Coutinho, EC; Jain, UK; Jyoti, K; Madan, J; Martis, EAF | 1 |
Futakuchi, M; Hirose, M; Kawabe, M; Shirai, T; Tamano, S | 1 |
Amidi, M; Hennink, WE; Jiskoot, W; van Riet, E; van Steenbergen, MJ; Verheul, RJ | 1 |
Calis, S; Crcarevska, MS; Geskovski, N; Glavas Dodov, M; Goracinova, K; Petrovska, V | 1 |
Al-Mohizea, AM; Al-Obeed, OA; Al-Robayan, AA; Alanazi, FK; Alsarra, IA; Yassin, AE | 1 |
Bahn, YE; Kim, BK; Kong, CS; Lee, KY; Park, KY | 1 |
Azab, B; Dash, R; Fisher, PB; Kundu, SC; Mandal, M; Pathak, A; Prashanth Kumar, BN; Puvvada, N; Sarkar, D; Venkatesan, P | 1 |
Chen, H; Cheng, M; Cheng, Z; He, B; Hong, X; Li, Q; Wan, T; Wu, J; Xu, H; Ye, T; Zha, B; Zhou, R | 1 |
Baradaran, B; Dastmalchi, S; Dobakhti, F; Hallaj-Nezhadi, S; Jalali, MB; Lotfipour, F; Valizadeh, H | 1 |
Pishko, MV; Yu, X | 1 |
Kanwar, JR; Kanwar, RK; Mahidhara, G | 1 |
Jiang, X; Li, Y; Qi, L; Wang, M; Xu, Z | 1 |
Chan, HY; Chen, MH; Lin, SY; Shen, FH; Wang, YJ; Yu, CK | 1 |
Kim, MK; Nam, KS; Shon, YH | 2 |
Iwamoto, Y; Kendall, CW; Rao, AV; Sugano, M; Torzsas, TL | 1 |
2 review(s) available for chitosan and Colonic Neoplasms
Article | Year |
---|---|
Carbohydrate polymers-based surface modified nano delivery systems for enhanced target delivery to colon cancer - A review.
Topics: Capecitabine; Chitosan; Colonic Neoplasms; Delayed-Action Preparations; Humans; Nanoparticle Drug Delivery System; Polymers | 2023 |
Bridging the Gap of Drug Delivery in Colon Cancer: The Role of Chitosan and Pectin Based Nanocarriers System.
Topics: Antineoplastic Agents; Chitosan; Colon; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; Humans; Pectins; Tissue Distribution | 2020 |
85 other study(ies) available for chitosan and Colonic Neoplasms
Article | Year |
---|---|
Stimuli-Responsive Drug Delivery of Doxorubicin Using Magnetic Nanoparticle Conjugated Poly(ethylene glycol)-
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Proliferation; Chitosan; Colonic Neoplasms; Doxorubicin; Drug Liberation; Glutathione; Humans; Magnetite Nanoparticles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Polyethylene Glycols; Polymers; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Chitosan oligosaccharide regulates AMPK and STAT1 pathways synergistically to mediate PD-L1 expression for cancer chemoimmunotherapy.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; B7-H1 Antigen; Cell Line, Tumor; Cell Survival; Chitosan; Colonic Neoplasms; Female; Immunotherapy; Mice; Mice, Inbred BALB C; Oligosaccharides; STAT1 Transcription Factor | 2022 |
Combinatorial therapy using RNAi and curcumin nano-architectures regresses tumors in breast and colon cancer models.
Topics: Animals; Chitosan; Colonic Neoplasms; Curcumin; Nanoparticles; RNA Interference | 2022 |
Alpha-mangostin and resveratrol, dual-drugs-loaded mucoadhesive thiolated chitosan-based nanoparticles for synergistic activity against colon cancer cells.
Topics: Chitosan; Colonic Neoplasms; Drug Carriers; Humans; Nanoparticles; Particle Size; Resveratrol; Xanthones | 2022 |
T7 Endonuclease I-mediated voltammetric detection of KRAS mutation coupled with horseradish peroxidase for signal amplification.
Topics: Breast Neoplasms; Cell Line, Tumor; Chitosan; Colonic Neoplasms; Deoxyribonuclease I; Electrochemical Techniques; Electrodes; Female; Gene Expression Regulation, Neoplastic; Gold; Horseradish Peroxidase; Humans; Ionic Liquids; Metal Nanoparticles; Mutation; Nanotubes, Carbon; Proto-Oncogene Proteins p21(ras); Signal Transduction | 2022 |
Fabrication and assessment of folic acid conjugated-chitosan modified PLGA nanoparticle for delivery of alpha terpineol in colon cancer.
Topics: Animals; Antioxidants; Chitosan; Colonic Neoplasms; Cyclohexane Monoterpenes; Drug Carriers; Folic Acid; Humans; Mice; Nanoparticles; Particle Size; Vascular Endothelial Growth Factor A | 2022 |
Orally delivered solid lipid nanoparticles of irinotecan coupled with chitosan surface modification to treat colon cancer: Preparation, in-vitro and in-vivo evaluations.
Topics: Animals; Chitosan; Colonic Neoplasms; Drug Carriers; Irinotecan; Lipids; Liposomes; Male; Nanoparticles; Particle Size; Rats; Rats, Wistar; Tissue Distribution | 2022 |
Targeting colon cancer stem cells using novel doublecortin like kinase 1 antibody functionalized folic acid conjugated hesperetin encapsulated chitosan nanoparticles.
Topics: Cell Line, Tumor; Cell Proliferation; Chitosan; Colonic Neoplasms; Doublecortin-Like Kinases; Folic Acid; Hesperidin; Humans; Intracellular Signaling Peptides and Proteins; Nanoparticles; Neoplastic Stem Cells; Protein Serine-Threonine Kinases | 2022 |
Gel-Free Single-Cell Culture Arrays on a Microfluidic Chip for Highly Efficient Expansion and Recovery of Colon Cancer Stem Cells.
Topics: Cell Culture Techniques; Chitosan; Colonic Neoplasms; Humans; Microfluidics; Microgels; Neoplastic Stem Cells | 2022 |
Folate decorated lipid chitosan hybrid nanoparticles of 5-fluorouracil for enhanced anticancer efficacy against colon cancer.
Topics: Cell Line, Tumor; Chitosan; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; Fluorouracil; Folic Acid; Humans; Lipids; Nanoparticles; Particle Size | 2022 |
Phenethyl Isothiocyanate-Conjugated Chitosan Oligosaccharide Nanophotosensitizers for Photodynamic Treatment of Human Cancer Cells.
Topics: Animals; Carcinoma; Chitosan; Colonic Neoplasms; Humans; Mice; Oligosaccharides; Reactive Oxygen Species | 2022 |
Early cancer detection using the fluorescent Ashwagandha chitosan nanoparticles combined with near-infrared light diffusion characterization: in vitro study.
Topics: Chitosan; Colonic Neoplasms; Coloring Agents; Humans; Nanoparticles; Plant Extracts; Spectroscopy, Fourier Transform Infrared | 2023 |
Studies on anti-colon cancer potential of nanoformulations of curcumin and succinylated curcumin in mannosylated chitosan.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chitosan; Colonic Neoplasms; Curcumin; Humans; Nanoparticles | 2023 |
Development of pH-Responsive
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Colonic Neoplasms; Curcumin; Drug Carriers; Drug Liberation; Humans; Hydrogen-Ion Concentration; Mice; Micelles | 2023 |
Synthesis and characterization of poly(3-hydroxybutyrate)/chitosan-graft poly (acrylic acid) conjugate hyaluronate for targeted delivery of methotrexate drug to colon cancer cells.
Topics: 3-Hydroxybutyric Acid; Caco-2 Cells; Chitosan; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; Humans; Hyaluronic Acid; Methotrexate; Pharmaceutical Preparations; Polymers | 2023 |
pH-responsive bufadienolides nanocrystals decorated by chitosan quaternary ammonium salt for treating colon cancer.
Topics: Ammonium Compounds; Bufanolides; Chitosan; Colonic Neoplasms; Humans; Hydrogen-Ion Concentration; Nanoparticles | 2023 |
The effect of chitosan hydrogel containing gold nanoparticle complex with paclitaxel on colon cancer cell line.
Topics: Cell Line, Tumor; Chitosan; Colonic Neoplasms; Gold; Humans; Hydrogels; Metal Nanoparticles; Nanoparticles; Paclitaxel | 2023 |
Folic acid-chitosan functionalized polymeric nanocarriers to treat colon cancer.
Topics: Animals; Caco-2 Cells; Chitosan; Colonic Neoplasms; Drug Carriers; Folic Acid; Humans; Nanoparticles; Polymers; Rats | 2023 |
An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy.
Topics: Acrylic Resins; Administration, Oral; Animals; Chitosan; Colonic Neoplasms; Contrast Media; Delayed-Action Preparations; Durapatite; Fluorouracil; Gadolinium; Gefitinib; HT29 Cells; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles | 2019 |
Cetuximab-conjugated chitosan-pectinate (modified) composite nanoparticles for targeting colon cancer.
Topics: Antineoplastic Agents; Caco-2 Cells; Cell Cycle Checkpoints; Cell Line, Tumor; Cetuximab; Chitosan; Colonic Neoplasms; Curcumin; Drug Delivery Systems; Drug Liberation; G2 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; Nanoparticles; Pectins | 2019 |
Targeted delivery and apoptosis induction of trans-resveratrol-ferulic acid loaded chitosan coated folic acid conjugate solid lipid nanoparticles in colon cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Chitosan; Colonic Neoplasms; Coumaric Acids; Drug Delivery Systems; Drug Liberation; Humans; Lipids; Nanoparticles; Resveratrol | 2020 |
Chitosan Coated Microparticles Enhance Simvastatin Colon Targeting and Pro-Apoptotic Activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Chitosan; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; HCT116 Cells; Humans; Hydrogen-Ion Concentration; Male; Microspheres; Particle Size; Polymethacrylic Acids; Rabbits; Simvastatin | 2020 |
Concomitant blockade of A2AR and CTLA-4 by siRNA-loaded polyethylene glycol-chitosan-alginate nanoparticles synergistically enhances antitumor T-cell responses.
Topics: Alginates; Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Chitosan; Colonic Neoplasms; CTLA-4 Antigen; Gene Expression Regulation, Neoplastic; Humans; Lymphocytes, Tumor-Infiltrating; Mice; Nanoparticles; Polyethylene Glycols; Receptor, Adenosine A2A; RNA, Small Interfering; T-Lymphocytes; Tumor Microenvironment | 2020 |
Production, physicochemical characterization, and anticancer activity of methotrexate-loaded phytic acid-chitosan nanoparticles on HT-29 human colon adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Chitosan; Colonic Neoplasms; Drug Carriers; Drug Liberation; Gels; HT29 Cells; Humans; Methotrexate; Nanoparticles; Phytic Acid | 2020 |
Functionalized layer-by-layer assembled film with directional 5-fluorouracil release to target colon cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Caco-2 Cells; Capsules; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Colonic Neoplasms; Drug Compounding; Fluorouracil; Folic Acid; Humans; Male; Polyesters; Rabbits; Rats; Spheroids, Cellular; Xenograft Model Antitumor Assays | 2020 |
Preparation and Characterization of a Novel Triple Composite Scaffold Containing Silk Fiborin, Chitosan, and Alginate for 3D Culture of Colonic Carcinoma Cells In Vitro.
Topics: Alginates; Cell Adhesion; Cell Culture Techniques; Cell Movement; Cell Proliferation; Chitosan; Colonic Neoplasms; Fibroins; HCT116 Cells; Humans; Tissue Scaffolds | 2020 |
Chitosan nanoparticles for oral photothermally enhanced photodynamic therapy of colon cancer.
Topics: Animals; Chitosan; Colonic Neoplasms; Hyperthermia, Induced; Indoles; Mice; Nanoparticles; Photochemotherapy | 2020 |
Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chick Embryo; Chitosan; Colonic Neoplasms; Drug Delivery Systems; Drug Liberation; Female; Humans; Interleukin-6; Lactic Acid; Magnetic Resonance Spectroscopy; Mice, Inbred BALB C; Nanoparticles; Neovascularization, Pathologic; Oligopeptides; Polyethylene Glycols; RNA, Small Interfering; Spectroscopy, Fourier Transform Infrared; Xenograft Model Antitumor Assays | 2020 |
Mucoadhesive chitosan and thiolated chitosan nanoparticles containing alpha mangostin for possible Colon-targeted delivery.
Topics: Antineoplastic Agents; Chitosan; Colon; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; HT29 Cells; Humans; Nanoparticles; Protein Kinase Inhibitors; Sulfhydryl Compounds; Xanthones | 2021 |
LncRNA ANRIL negatively regulated chitooligosaccharide-induced radiosensitivity in colon cancer cells by sponging miR-181a-5p.
Topics: Cell Line, Tumor; Chitin; Chitosan; Colonic Neoplasms; Humans; MicroRNAs; Oligosaccharides; Radiation Tolerance; RNA, Long Noncoding | 2021 |
Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Colonic Neoplasms; Female; Humans; Hyaluronic Acid; Hypoxia-Inducible Factor 1, alpha Subunit; Magnetic Iron Oxide Nanoparticles; Mice; Mice, Inbred BALB C; RNA, Small Interfering; STAT3 Transcription Factor | 2021 |
Gamma radiation synthesis of a novel amphiphilic terpolymer hydrogel pH-responsive based chitosan for colon cancer drug delivery.
Topics: Acrylamides; Acrylates; Alkanesulfonates; Antimetabolites, Antineoplastic; Chitosan; Colonic Neoplasms; Cross-Linking Reagents; Drug Delivery Systems; Drug Liberation; Fluorouracil; Gamma Rays; Humans; Hydrogels; Hydrogen-Ion Concentration; Kinetics; Polymers; Surface-Active Agents; Water | 2021 |
In vitro and in vivo combinatorial anticancer effects of oxaliplatin- and resveratrol-loaded N,O-carboxymethyl chitosan nanoparticles against colorectal cancer.
Topics: Chitosan; Colonic Neoplasms; Drug Carriers; Humans; Nanoparticles; Oxaliplatin; Resveratrol | 2021 |
NEAT1 siRNA Packed with Chitosan Nanoparticles Regulates the Development of Colon Cancer Cells via lncRNA NEAT1/miR-377-3p Axis.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Chitosan; Colon; Colonic Neoplasms; Down-Regulation; Humans; MicroRNAs; Nanoparticles; RNA, Long Noncoding; RNA, Small Interfering; Transfection | 2021 |
Chitosan-coated Zn-metal-organic framework nanocomposites for effective targeted delivery of LNA-antisense miR-224 to colon tumor: in vitro studies.
Topics: Cell Line, Tumor; Chitosan; Colonic Neoplasms; Folic Acid; Humans; Metal-Organic Frameworks; MicroRNAs; Nanocomposites; Spectroscopy, Fourier Transform Infrared; Zinc | 2022 |
Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells.
Topics: Anticholesteremic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Chitosan; Colonic Neoplasms; Epithelial Cell Adhesion Molecule; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Liver Neoplasms; Neoplastic Stem Cells; Tumor Cells, Cultured; Wnt Signaling Pathway | 2017 |
Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
Topics: Adsorption; Animals; Antibiotics, Antineoplastic; Aptamers, Nucleotide; Cell Survival; Chitosan; CHO Cells; Colonic Neoplasms; Cricetulus; Drug Carriers; Drug Compounding; Drug Liberation; Epirubicin; Female; Humans; Lactic Acid; MCF-7 Cells; Mice, Inbred BALB C; Mucin-1; Nanomedicine; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Surface Properties; Technology, Pharmaceutical; Time Factors; Tumor Burden | 2017 |
In Vitro Collapsing Colon Cancer Cells by Selectivity of Disulfiram-Loaded Charge Switchable Nanoparticles Against Cancer Stem Cells.
Topics: Acetaldehyde Dehydrogenase Inhibitors; Animals; Caco-2 Cells; Chitosan; Colonic Neoplasms; Delayed-Action Preparations; Disulfiram; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Mice, Inbred BALB C; Nanoparticles; Neoplastic Stem Cells; Patents as Topic; Serum Albumin; Tumor Microenvironment | 2017 |
Chitosan nanoparticle-based delivery of fused NKG2D-IL-21 gene suppresses colon cancer growth in mice.
Topics: Animals; Cell Line, Tumor; Chitosan; Colonic Neoplasms; Drug Delivery Systems; Gene Transfer Techniques; Genetic Therapy; GPI-Linked Proteins; Humans; Intercellular Signaling Peptides and Proteins; Interleukins; Killer Cells, Natural; Mice, Inbred BALB C; Nanoparticles; Recombinant Fusion Proteins; T-Lymphocytes; Tissue Distribution; Xenograft Model Antitumor Assays | 2017 |
[Experimental research of neutrophil gelatinase-associated lipocalin siRNA encapsulated by urocanic acid-coupled chitosan on colon cancer cells].
Topics: Cell Line, Tumor; Chitosan; Colonic Neoplasms; Humans; Lipocalin-2; RNA, Small Interfering; Transfection; Urocanic Acid | 2017 |
Pro-inflammatory chitosan/poly(γ-glutamic acid) nanoparticles modulate human antigen-presenting cells phenotype and revert their pro-invasive capacity.
Topics: Antigen-Presenting Cells; Cell Differentiation; Cell Movement; Cell Polarity; Cell Proliferation; Cell Survival; Chitosan; Colonic Neoplasms; Dendritic Cells; Endocytosis; Humans; Inflammation; Interleukin-10; Macrophages; Nanoparticles; Neoplasm Invasiveness; Particle Size; Phenotype; Polyglutamic Acid; T-Lymphocytes | 2017 |
Chitosan oligosaccharides with degree of polymerization 2-6 induces apoptosis in human colon carcinoma HCT116 cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Chitosan; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Mice; Mice, Nude; Oligosaccharides | 2018 |
Green synthesis of antimicrobial and antitumor N,N,N-trimethyl chitosan chloride/poly (acrylic acid)/silver nanocomposites.
Topics: Anti-Infective Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Colonic Neoplasms; Green Chemistry Technology; Humans; Metal Nanoparticles; Microbial Sensitivity Tests; Nanocomposites; Silver; Staphylococcus aureus | 2018 |
Facile development, characterization, and optimization of new metformin-loaded nanocarrier system for efficient colon cancer adjunct therapy.
Topics: Cell Line, Tumor; Chitosan; Colonic Neoplasms; Drug Carriers; Drug Liberation; Humans; Metformin; Nanoparticles; Particle Size | 2018 |
Capecitabine encapsulated chitosan succinate-sodium alginate macromolecular complex beads for colon cancer targeted delivery: in vitro evaluation.
Topics: Alginates; Animals; Capecitabine; Capsules; Cecum; Cell Survival; Chitosan; Colonic Neoplasms; Drug Carriers; Drug Liberation; Glucuronic Acid; Hexuronic Acids; HT29 Cells; Humans; Hydrogen-Ion Concentration; Kinetics; Rats; Temperature | 2018 |
Core/shell multicellular spheroids on chitosan as in vitro 3D coculture tumor models.
Topics: Cell Line, Tumor; Chitosan; Coculture Techniques; Colonic Neoplasms; Fibroblasts; Humans; Mesenchymal Stem Cells; Models, Biological; Spheroids, Cellular | 2018 |
Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line; Cell Survival; Chitosan; Colonic Neoplasms; Curcumin; Drug Carriers; Drug Liberation; Drug Stability; Humans; Male; Nanoparticles; Pectins; Rats, Sprague-Dawley | 2018 |
A colon-specific delivery system for quercetin with enhanced cancer prevention based on co-axial electrospinning.
Topics: Alginates; Antioxidants; Apoptosis; Caco-2 Cells; Cell Cycle; Cell Line; Cell Proliferation; Cell Survival; Chitosan; Colon; Colonic Neoplasms; Drug Delivery Systems; Humans; Nanoparticles; Prebiotics; Quercetin | 2018 |
Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery.
Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Survival; Chitosan; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; Drug Liberation; Galactose; Glycosylation; Humans; Leucovorin; Nanoparticles; Porosity; Silicon Dioxide; Spectroscopy, Fourier Transform Infrared; Static Electricity; Thermogravimetry; Thymidylate Synthase | 2018 |
Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bufanolides; Chitosan; Colonic Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; HCT116 Cells; Humans; Mice, Nude; Micelles; Oligopeptides; Oligosaccharides; Rhodamine 123; Tumor Burden; Vitamin E | 2018 |
Minicapsules encapsulating nanoparticles for targeting, apoptosis induction and treatment of colon cancer.
Topics: Animals; Apoptosis; Capsules; Caspase 3; Cell Line, Tumor; Cell Survival; Chitosan; Colonic Neoplasms; DNA Fragmentation; Folic Acid; Mice; Mice, Inbred C57BL; Nanoparticles; Staurosporine; Xenograft Model Antitumor Assays | 2019 |
Black rice anthocyanins embedded in self-assembled chitosan/chondroitin sulfate nanoparticles enhance apoptosis in HCT-116 cells.
Topics: Anthocyanins; Antineoplastic Agents; Apoptosis; Chitosan; Chondroitin Sulfates; Colonic Neoplasms; HCT116 Cells; Humans; Nanoparticles; Oryza; Particle Size | 2019 |
Wheat germ agglutinin-functionalised crosslinked polyelectrolyte microparticles for local colon delivery of 5-FU: in vitro efficacy and in vivo gastrointestinal distribution.
Topics: Alginates; Animals; Antimetabolites, Antineoplastic; Caco-2 Cells; Chitosan; Colon; Colonic Neoplasms; Drug Carriers; Fluorouracil; Glucuronic Acid; Hexuronic Acids; Humans; Male; Rats; Rats, Wistar; Triticum; Wheat Germ Agglutinins | 2013 |
5-aminolevulinic acid-incorporated nanoparticles of methoxy poly(ethylene glycol)-chitosan copolymer for photodynamic therapy.
Topics: Aminolevulinic Acid; Cell Line, Tumor; Chitosan; Colonic Neoplasms; Drug Carriers; Humans; Nanoparticles; Particle Size; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Protoporphyrins | 2013 |
Non-invasive optical imaging of cathepsin B with activatable fluorogenic nanoprobes in various metastatic models.
Topics: Cathepsin B; Cell Line, Tumor; Chitosan; Colonic Neoplasms; Fluorescent Dyes; Humans; Models, Biological; Nanostructures; Neoplasm Metastasis; Optical Imaging | 2014 |
Preparation and evaluation of chitosan based thermoreversible gels for intraperitoneal delivery of 5-fluorouracil (5-FU).
Topics: Animals; Antimetabolites, Antineoplastic; Chitosan; Colonic Neoplasms; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Fibroblasts; Fluorouracil; Gels; Glycerol; Injections, Intraperitoneal; Lethal Dose 50; Male; Mice; Mice, Inbred BALB C; Toxicity Tests, Acute; Tumor Burden | 2013 |
In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Blood Coagulation; Cell Cycle; Cell Line; Cell Line, Tumor; Chitosan; Colonic Neoplasms; Curcumin; Drug Carriers; Drug Delivery Systems; Female; Fluorouracil; Hemolysis; HT29 Cells; Humans; Hydrogen-Ion Concentration; Membrane Potentials; Mice; Nanoparticles; Spectroscopy, Fourier Transform Infrared | 2014 |
Paclitaxel and gemcitabine combinational drug-loaded mucoadhesive delivery system in the treatment of colon cancers.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Cell Survival; Chitosan; Colonic Neoplasms; Deoxycytidine; Drug Carriers; Drug Liberation; Drug Therapy, Combination; Gemcitabine; Humans; Mice; Nanoparticles; Paclitaxel; Succinic Anhydrides; Survival Rate; Xenograft Model Antitumor Assays | 2015 |
Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment.
Topics: Animals; Biological Availability; Cell Cycle; Cell Line, Tumor; Chitosan; Colonic Neoplasms; Curcumin; Delayed-Action Preparations; Fluorouracil; Humans; Membrane Potential, Mitochondrial; Mice; Nanoparticles | 2014 |
Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc.
Topics: Animals; Apoptosis; Caco-2 Cells; Calcium; Cattle; Chitosan; Colonic Neoplasms; Drug Delivery Systems; Humans; Inhibitor of Apoptosis Proteins; Iron; Lactoferrin; Mice; Nanocapsules; Neoplastic Stem Cells; Survivin; Zinc | 2015 |
Microencapsulation of coupled folate and chitosan nanoparticles for targeted delivery of combination drugs to colon.
Topics: Capsules; Chitosan; Colon; Colonic Neoplasms; Drug Carriers; Folic Acid; Humans; Nanoparticles; Polymethacrylic Acids | 2015 |
Oral delivery of nanoparticles containing anticancer SN38 and hSET1 antisense for dual therapy of colon cancer.
Topics: Administration, Oral; Animals; Camptothecin; Cell Line, Tumor; Chitosan; Colonic Neoplasms; Disease Models, Animal; Drug Carriers; Drug Liberation; Drug Stability; Histone-Lysine N-Methyltransferase; Humans; Irinotecan; Mice; Nanoparticles; Oligonucleotides, Antisense; Spectroscopy, Fourier Transform Infrared; Xenograft Model Antitumor Assays | 2015 |
Lymph node mapping using quantum dot-labeled polymersomes.
Topics: Animals; Cell Line, Tumor; Chitosan; Coated Materials, Biocompatible; Colonic Neoplasms; Contrast Media; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Mice, Nude; Nanocapsules; Particle Size; Quantum Dots; Reproducibility of Results; Sensitivity and Specificity; Staining and Labeling; Theranostic Nanomedicine | 2015 |
Optimization of chitosan nanoparticles for colon tumors using experimental design methodology.
Topics: Animals; Chitosan; Colonic Neoplasms; Fluorouracil; Humans; Models, Biological; Nanoparticles | 2016 |
Improving Antitumor Activity with N-Trimethyl Chitosan Entrapping Camptothecin in Colon Cancer and Lung Cancer.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Colonic Neoplasms; Drug Carriers; Female; Lung Neoplasms; Mice; Mice, Inbred BALB C | 2015 |
Targeted delivery of small interfering RNA to colon cancer cells using chitosan and PEGylated chitosan nanoparticles.
Topics: Cell Line, Tumor; Chitosan; Colonic Neoplasms; Humans; Molecular Targeted Therapy; Nanoparticles; Polyethylene Glycols; RNA, Small Interfering | 2016 |
Chitooligosaccharides promote radiosensitivity in colon cancer line SW480.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitin; Chitosan; Colonic Neoplasms; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; G2 Phase Cell Cycle Checkpoints; Humans; Oligosaccharides; Radiation Tolerance; Radiation-Sensitizing Agents | 2016 |
Water-Based Chitosan for Thymine Conjugation: A Simple, Efficient, Effective, and Green Pathway to Introduce Cell Compatible Nucleic Acid Recognition.
Topics: Cell Line; Cell Survival; Chitosan; Circular Dichroism; Colonic Neoplasms; DNA; Electrophoretic Mobility Shift Assay; Green Chemistry Technology; Humans; Hydrogen-Ion Concentration; Microscopy, Electron, Transmission; Poly A; Solubility; Solvents; Thymine; Water | 2016 |
Soluble curcumin amalgamated chitosan microspheres augmented drug delivery and cytotoxicity in colon cancer cells: In vitro and in vivo study.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Area Under Curve; beta-Cyclodextrins; Chitosan; Colon; Colonic Neoplasms; Curcumin; Drug Delivery Systems; Drug Liberation; HT29 Cells; Humans; Male; Metabolic Clearance Rate; Mice; Microscopy, Electron, Scanning; Microspheres; Molecular Dynamics Simulation; Particle Size; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2016 |
Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesi
Topics: Animals; Body Weight; Carcinogenicity Tests; Carcinogens; Chitin; Chitosan; Colonic Neoplasms; Diethylnitrosamine; Female; Glutathione Peroxidase; Liver Neoplasms, Experimental; Male; Mammary Neoplasms, Animal; Organ Size; Quinoxalines; Rats; Rats, Inbred F344 | 2008 |
In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Survival; Chitosan; Colon; Colonic Neoplasms; Drug Compounding; Drug Delivery Systems; Electrochemistry; Excipients; Fluorouracil; HT29 Cells; Humans; Hyaluronic Acid; Ligands; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Photometry; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2008 |
Influence of the degree of acetylation on the enzymatic degradation and in vitro biological properties of trimethylated chitosans.
Topics: Acetylation; Adenocarcinoma; Animals; Biopolymers; Cell Line, Tumor; Cell Survival; Chickens; Chitosan; Colonic Neoplasms; Electric Impedance; Epithelial Cells; Humans; Hydrolysis; L-Lactate Dehydrogenase; Methylation; Molecular Weight; Muramidase; Nuclear Magnetic Resonance, Biomolecular; Tight Junctions | 2009 |
Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
Topics: Adsorption; Alginates; Animals; Antimetabolites, Antineoplastic; Buffers; Calcium; Chelating Agents; Chitosan; Colonic Neoplasms; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Fluorouracil; Hemagglutination; Humans; Hydrogels; Hydrogen-Ion Concentration; Kinetics; Microspheres; Mucins; Particle Size; Solubility; Surface Properties; Swine; Wheat Germ Agglutinins | 2009 |
New targeted-colon delivery system: in vitro and in vivo evaluation using X-ray imaging.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Chemistry, Pharmaceutical; Chitosan; Colon; Colonic Neoplasms; Dogs; Drug Delivery Systems; Excipients; Fluorouracil; Gastrointestinal Tract; Male; Radiography; Rats; Solubility; Tablets | 2010 |
Antiproliferative effect of chitosan-added kimchi in HT-29 human colon carcinoma cells.
Topics: Acetylation; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma; Cell Proliferation; Chitosan; Colonic Neoplasms; Cyclooxygenase 2; Diet; Fermentation; Food, Fortified; Gene Expression; HT29 Cells; Humans; Inhibitor of Apoptosis Proteins; NF-kappa B; Nitric Oxide Synthase; Proto-Oncogene Proteins c-bcl-2; Vegetables; Viscosity | 2010 |
The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer.
Topics: Animals; Antineoplastic Agents; Celecoxib; Cell Cycle; Cell Proliferation; Chitosan; Colonic Neoplasms; Cytoskeleton; Durapatite; HT29 Cells; Humans; Mice; Mice, Nude; Nanocomposites; Pyrazoles; Sulfonamides | 2011 |
Synthesis and efficient hepatocyte targeting of galactosylated chitosan as a gene carrier in vitro and in vivo.
Topics: Animals; Cell Line, Tumor; Chitosan; Colonic Neoplasms; Female; Galactose; Genetic Vectors; Granulocyte-Macrophage Colony-Stimulating Factor; Hepatocytes; Interleukins; Liver Neoplasms; Materials Testing; Mice; Mice, Inbred BALB C; Molecular Structure; Nanoparticles; Random Allocation; Recombinant Fusion Proteins; Spectroscopy, Fourier Transform Infrared; Tissue Distribution; Transfection | 2011 |
Preparation of chitosan-plasmid DNA nanoparticles encoding interleukin-12 and their expression in CT-26 colon carcinoma cells.
Topics: Animals; Carcinoma; Cell Line, Tumor; Cell Survival; Chitosan; Colonic Neoplasms; Culture Media, Conditioned; Electrophoresis, Agar Gel; Gene Transfer Techniques; Humans; Interleukin-12; Mice; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Plasmids; Recombinant Proteins; Static Electricity; Surface Properties; Transfection | 2011 |
Nanoparticle-based biocompatible and targeted drug delivery: characterization and in vitro studies.
Topics: Antineoplastic Agents, Phytogenic; Biocompatible Materials; Caco-2 Cells; Cell Survival; Chitosan; Colonic Neoplasms; Dextran Sulfate; Drug Carriers; Drug Compounding; Fluorescence; Humans; Kinetics; Microscopy, Electron, Scanning; Molecular Targeted Therapy; Nanoparticles; Paclitaxel; Particle Size; Photoelectron Spectroscopy; Polyethylene Glycols; Surface Properties; Wheat Germ Agglutinins | 2011 |
Novel alginate-enclosed chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy.
Topics: Administration, Oral; Alginates; Animals; Antineoplastic Agents; Calcium Phosphates; Cattle; Chitosan; Colonic Neoplasms; Endocytosis; Glucuronic Acid; Hexuronic Acids; Humans; Iron; Lactoferrin; Mice; Nanoparticles; Paclitaxel; Xenograft Model Antitumor Assays | 2012 |
Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles.
Topics: Cell Line; Cell Line, Tumor; Cell Proliferation; Chitosan; Colonic Neoplasms; Copper; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Liver; Liver Neoplasms; Nanostructures; Particle Size; Stomach Neoplasms | 2005 |
Chitosan prevents the development of AOM-induced aberrant crypt foci in mice and suppressed the proliferation of AGS cells by inhibiting DNA synthesis.
Topics: Animals; Azoxymethane; Blotting, Western; Carcinogens; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Colonic Neoplasms; DNA Replication; Flow Cytometry; Humans; Jurkat Cells; Male; Mice; Mice, Inbred ICR; Molecular Weight; Precancerous Conditions; Stomach Neoplasms; Time Factors; Urinary Bladder Neoplasms | 2007 |
Chemopreventive effect of chitosan oligosaccharide against colon carcinogenesis.
Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; Chitosan; Colonic Neoplasms; HT29 Cells; Humans; Oligosaccharides | 2007 |
Inhibition of proinflammatory cytokine-induced invasiveness of HT-29 cells by chitosan oligosaccharide.
Topics: Adenocarcinoma; Blotting, Western; Cell Movement; Chitosan; Colonic Neoplasms; Cytokines; Drug Interactions; Electrophoresis, Polyacrylamide Gel; HT29 Cells; Humans; Interferon-gamma; Interleukin-1alpha; Lymphotoxin-alpha; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Nitric Oxide Synthase Type II; Nitriles | 2007 |
The influence of high and low molecular weight chitosan on colonic cell proliferation and aberrant crypt foci development in CF1 mice.
Topics: Animals; Azoxymethane; Carcinogens; Cell Division; Chitin; Chitosan; Colon; Colonic Neoplasms; Dietary Fiber; Female; Mice; Molecular Weight; Precancerous Conditions; Random Allocation; Solubility | 1996 |